e-Therapeutics PLC's (LON:ETX) Ray Barlow says they're actively engaged in exploring all organic and non-organic opportunities that have the potential to create incremental value for its shareholders.
He adds that multiple proposals for its artificial intelligence-based drug research products have been sent to potential partners and customers.